Craig Steger is the Managing Director of Life Sciences at Outcome Capital, based in the United States. He has been with Outcome Capital since June 2022, initially serving as Director before being promoted to his current role in June 2024.

Craig brings extensive experience in the life sciences sector, having held senior positions at various organizations. Prior to joining Outcome Capital, he was a Consultant at Forge 4ward and Vice President of Sales at iSpecimen.

His earlier roles include Director of Sales and Business Development at PerkinElmer, General Manager of International Business at BD Diagnostics, and Director of Emerging Technologies at Thermo Fisher Scientific. Craig also held managerial positions at GE Healthcare and Invitrogen.

Craig's career reflects a strong focus on strategic alliances, business development, and sales within the life sciences industry.